Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: Incidence and association with atrial fibrillation

Stroke

Volumn 41, Issue 9, 2010, Pages 1990-1995

  Awadh, Mostafa ^a   MacDougall, Niall ^a   Santosh, Celestine ^b   Teasdale, Evelyn ^b   Baird, Tracey ^c   Muir, Keith W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Southern General Hospital   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

acute care; atrial fibrillation; embolism; thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT ISCHEMIC STROKE; RETROSPECTIVE STUDY; STROKE; ATRIAL FIBRILLATION; COMPLICATION; INCIDENCE; MIDDLE AGED; STATISTICAL MODEL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 77956403095     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.569459     Document Type: Article

References (39)

1. Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and per-fusion abnormalities in early neurological deterioration. Stroke. 2009;40: e443-e450.
2. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol. 2005;62:393-397.
3. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry. 1990;53:824-829.
4. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke. 2001;32:661-668.
5. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59: 862-867.
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
7. Larrue V, von Kummer RR, Müller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32: 438-441.
8. Stafford PJ, Strachan CJ, Vincent R, Chamberlain DA. Multiple micro-emboli after disintegration of clot during thrombolysis for acute myo-cardial infarction. BMJ. 1989;299:1310-1312.
9. Lescure M, Lagorce P, Caussanel JP, Malbec M. Myocardial infarction, late fibrinolysis and resolving cerebral embolism. Ann Cardiol Angeiol (Paris). 1993;42:25-27.
10. Bautista RE. Embolic stroke following thrombolytic therapy for myo-cardial infarction in a patient with preexisting ventricular thrombi. Stroke. 1995;26:324-325.
11. Sloan MA, Price TR, Terrin ML, Forman S, Gore JM, Chaitman BR, Hodges M, Mueller H, Rogers WJ, Knatterud GL, Braunwald E. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction: the TIMI-II pilot and randomized clinical trial combined experience. Stroke. 1997;28:1107-1114.
12. Chang GY. An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction. Eur J Neurol. 2001;8:267-268.
13. Chang MC, Lee AY, Chang WF, Chen TJ. Embolic cerebral infarction and gastrointestinal hemorrhage following thrombolytic therapy for acute myocardial infarction. Echocardiography. 2002;19:139-141.
14. De Simone N, Sassone B, Vinelli S, Pancaldi LG, Di Pasquale G. Non-hemorrhagic stroke, of possible aortoembolic origin, in the course of acute myocardial infarct treated with thrombolysis. Ital Heart J Suppl. 2002;3:344-348.
15. Pape LA, Love DG, Gore JM. Massive thromboembolic stroke and death after fibrinolytic therapy of St. Jude prosthetic mitral valve thrombosis: documentation by transthoracic Doppler echocardiography. Am Heart J. 1994;128:406-409.
16. Serafini O, Bisignani G, Plastina F. Acute dysfunction from thrombosis of a prosthetic mitral valve: thrombolysis with rt-PA in the clinical emergency phase. G Ital Cardiol. 1998;28:387-391.
17. Koca V, Bozat T, Sarikamis C, Akkaya V, Yavuz S, Ozdemir A. The use of transesophageal echocardiography guidance of thrombolytic therapy in prosthetic mitral valve thrombosis. J Heart Valve Dis. 2000;9:374-378.
18. Lengyel M, Vandor L. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography. J Heart Valve Dis. 2001;10:636-649.
19. Braceya TS, Langrisha C, Darbyb M, Soara J. Cerebral infarction following thrombolysis for massive pulmonary embolism. Resuscitation. 2006;68:135-137.
20. Meissner W, Lempert T, Saeuberlich-Kniggeb S, Bocksch W, Pape UF. Fatal embolic myocardial infarction after systemic thrombolysis for stroke. Cerebrovasc Dis. 2006;22:213-214.
21. Mehdiratta M, Murphy C, Al-Harthi A, Teal PA. Myocardial infarction following t-PA for acute stroke. Can J Neurol Sci. 2007;34:417-420.
22. Gomez-Beldarrain M, Telleria M, Garcia-Monco JC. Peripheral arterial embolism during thrombolysis for stroke. Neurology. 2006;67: 1096-1097.
23. Yasaka M, Yamaguchi T, Yonehara T, Moriyasu H. Recurrent emboli-zation during intravenous administration of tissue plasminogen activator in acute cardioembolic stroke: a case report. Angiology. 1994;45: 481-484.
24. Kontny F, Dale J, Hegrenaes L, Lem P, Søberg T, Morstøl T. Left ventricular thrombosis and arterial embolism after thrombolysis in acute anterior myocardial infarction: predictors and effects of adjunctive anti-thrombotic therapy. Eur Heart J. 1993;14:1489-1492.
25. Derex L, Nighoghossian N, Perinetti M, Honnorat J, Trouillas P. Throm-bolytic therapy in acute ischemic stroke patients with cardiac thrombus. Neurology. 2001;57:2122-2125. (Pubitemid 33126887)
26. Kissela BM, Kothari RU, Tomsick TA, Woo D, Broderick J. Emboli-zation of calcific thrombi after tissue plasminogen activator treatment. J Stroke Cerebrovasc Dis. 2001;10:135-138.
27. Lai CC, Hu CJ. A left MCA territory infarction during intravenous recombinant tissue plasminogen activator therapy for right MCA territory ischaemic stroke. Emerg Med J. 2006;23:e11.
28. Georgiadis D, Engelter S, Tettenborn B, Hungerbühler H, Luethy R, Müller F, Arnold M, Giambarba C, Baumann CR, von Büdingen HC, Lyrer P, Baumgartner RW. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis. Circulation. 2006;114: 237-241.
29. Yalcin-Cakmakli G, Akpinar E, Topcuoglu MA, Dalkara T. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion. J Stroke Cerebrovasc Dis. 2009;18: 74-77.
30. Anderson CD, Bergman DL, Bernstein RA. Recurrent artery-to-artery embolism during intravenous t-PA therapy for acute ischemic stroke. Neurocrit Care. 2005;3:54-56.
31. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004; 35:1647-1651.
32. Kang DW, Latour LL, Chalela JA, Dambrosia J, Warach S. Early ische-mic lesion recurrence within a week after acute ischemic stroke. Ann Neurol. 2003;54:66-74.
33. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci. 2008;267:57-61.
34. Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Yamashita S, Aoki J. IV t-PA therapy in acute stroke patients with atrial fibrillation. J Neurol Sci. 2009;276:6-8.
35. Kaarisalo MM, Immonen-Räihä P, Marttila RJ, Salomaa V, Kaarsalo E, Salmi K, Sarti C, Sivenius J, Torppa J, Tuomilehto J. Atrial fibrillation and stroke: mortality and causes of death after the first acute ischemic stroke. Stroke. 1997;28:311-315. (Pubitemid 27096996)
36. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001;32:2333-2337.
37. Dulli DA, Stanko H, Levine RL. Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology. 2003;22:118-123.
38. Kimura K, Minematsu K, Yamaguchi T, for the Japan, Multicenter Stroke Investigators' Collaboration (J-MUSIC). Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2005;76:679-683.
39. Porebska A, Nowacki P, Safranowb K, Nowik M. Hemodynamic blood flow disturbances in the middle cerebral arteries in patients with atrial fibrillation during acute ischemic stroke. Clin Neurol Neurosurg. 2008; 110:434-440.